MedTrace Logo

ANTIPIGMENTING OR DEPIMENTING EFFICACY UNDER PART OF VISIBLE LIGHT

NCT06945393 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2025-04-25

No results posted yet for this study

Summary

The study intends to validate a protocol and define a positive reference to evaluate the efficacy of anti-pigmenting and depigmenting agents under part of visible Light exposures, between 400nm to 450nm.

It is carried out on cosmetic products for which the safety has been assured by a toxicologist, with the aim of confirming the efficacy of the products, which will be used by a large number of consumers under normal and reasonably foreseeable use conditions.

Conditions

  • Visible Light Exposure on Healthy Back Skin

Interventions

OTHER

Cosmetic topical products

Cosmetic topical products efficacy evaluation

Sponsors & Collaborators

  • L'Oreal

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-10-21
Primary Completion
2022-05-21
Completion
2022-05-21

Countries

  • Romania

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06945393 on ClinicalTrials.gov